Genomic Health Expands Oncotype DX Franchise Into Spain, Portugal
April 07, 2010
Genomic Health Expands Oncotype DX Franchise Into Spain, Portugal
The exclusive distribution agreement with Palex Medical, a distributor of medical diagnostic services and devices in Europe, will bring Oncotype DX to breast cancer patients in Spain and Portugal.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Genomic Health Signs Up Oncotype DX Distributor for Spain, Portugal
March 25, 2010 / GenomeWeb Daily News - Deal with NewBridge Allows Genomic Health to Expand Oncotype DX into Africa, Middle East
August 13, 2012 / GenomeWeb Daily News - Prospective Comparison of Oncotype DX and Central Pathology Assessment Shows HER2 Discordance
July 3, 2012 / Pharmacogenomics Reporter - MDx Highlights from the American Society of Clinical Oncology's 2012 Meeting
June 13, 2012 / Pharmacogenomics Reporter - Genomic Health Expanding Sales Force by 20 Percent; Starts Prostate Dx Studies
January 9, 2012 / GenomeWeb Daily News